 |
CAESA LAB Inc., Canada |    |
|
|
| |
CAESA-LAB Inc is a manufacturer and global supplier of disposable plastic labware; pipettors; laboratory equipment & diagnostic test kits. Our products are used in Biotechnology, Biomedical, Environmental, Forensics, Clinical, Research, Hospital, etc.
|
 |
 |
Caliper Life Sciences, United States |  |
|
|
| |
Caliper Technologies Corp. - The leading microfluidic lab-on-a-chip company, offering drug discovery systems, automated electrophoresis instruments, and LabChip technology partnerships to the life sciences industry
|
 |
 |
Caliper Technologies Corporation, United States | |
|
|
| |
Caliper develops LabChip® systems that perform biochemical experiments using microfluidic devices. Our products include the AMS90 SE for rapid electrophoresis of DNA and protein samples, and the Caliper® 250 System for drug discovery, which miniaturizes,
|
 |
|
Cambridge Biomedical Research Campus, United Kingdom |     |
|
|
| |
The Campus is home to world-leading, Nobel-Prize-winning, expertise in molecular biology, genetics, nutrition and monoclonal antibodies which underpins a comprehensive portfolio of disease-specific research programmes and
|
 |
 |
Cambridge BioScience, United Kingdom |   |
|
|
| |
Cambridge BioScience is a leading distributor in the UK and Ireland of products and services for life science research.
We are one of the longest established companies serving this market and have built a comprehensive product portfolio.
|
 |
 |
Cambridge Clinical Research (CCR), United Kingdom |    |
|
|
| |
Cambridge Clinical Research (CCR) is a UK-based secondary care patient recruitment company dedicated to conducting clinical trials across all therapeutic disease areas in Phases 2, 3 and 4.
|
 |
 |
Cambridge Cognition, United Kingdom |   |
|
|
| |
Cambridge Cognition Ltd specialises in computerised cognitive testing. Based in Cambridge, England, the company supplies products and services based on CANTAB®, the Cambridge Neuropsychological Test Automated Battery.
|
|
 |
Cambridge Group Ltd, The, United States |     |
|
|
| |
Over 25 years in Business providing specialized executive search and contract staffing services in the Pharmaceutical, CRO, Bio-tech and Discovery Industries, focusing in:
-Biostatistics
-Clinical Data Mgt
-Statistical Programming
-Bioinformatics
|
 |
 |
Cambridge Healthtech Institute (CHI), United States |  |
|
|
| |
Cambridge Healthtech Institute: Your Life Science Information Resource. Our conferences relating to genomics, drug discovery, and proteomics are world-renown for their outstanding quality and value.
|
 |
 |
Cambridge Research Biochemicals (CRB), United Kingdom |  |
|
|
| |
CRB provides high quality custom peptides, custom polyclonal antibodies and custom labelled peptides to the worlds research communities with speed and flexibility.
|
 |
 |
Cambridge University - Surgery, United Kingdom |    |
|
|
| |
The Department of Surgery encompasses Transplantation, Neurosurgery, Stem Cell Medicine, Orthopaedic Surgery, Surgical Oncology and Cardiac Surgery
|
 |
 |
Canbex, United Kingdom |  |
|
|
| |
The company develops peripherally-acting cannabinoid antagonists for the treatment of multiple sclerosis (MS) and other neurodegenerative diseases.
|
|
 |
Cancer Research and Biostatistics (CRAB), United States |   |
|
|
| |
CRAB® is an international leader in designing, managing and analyzing therapeutic and prevention cancer clinical trials.
|
|
 |
cancer411.org, United States |     |
|
|
| |
Comprehensive Cancer Clinical Trials Information.
|
 |
 |
Can-Fite BioPharma Ltd, Israel |  |
|
|
| |
Can-Fite is an Israeli science-based biopharmaceutical company with the mission to develop novel treatments for major human diseases with large unmet needs. The company research and development efforts are aimed in providing drugs that are highly efficaci
|
|
 |
CarboGen AG, Switzerland | |
|
|
| |
We are dedicated to helping pharmaceutical and biopharmaceutical companies
reduce the time, cost and risks associated with drug development. We combine the
world-class chemistry skills of CARBOGEN AMCIS to provide seamless development and commercializat
|
 |
 |
Cardiome Pharma Corp., Canada | |
 |
|
| |
Cardiome Pharma Corp (formerly Nortran Pharmaceuticals) - a Vancouver-based drug discovery and development company - has an interest in cardiac disease and conditions, and several potential therapies to treat arrhythmia within its antiarrhythmic program.
|
 |
 |
Carigent Therapeutics, United States | |
|
|
| |
Carigent is a privately held biotechnology firm located in New Haven, CT dedicated to the development of next-generation therapeutics and diagnostic agents using a propriety drug delivery platform that is extremely versatile and robust.
|
|
 |
Cecil Instruments Ltd, United Kingdom |   |
|
|
| |
Cecil Instruments are leading designers and manufacturers of UV/Visible Spectrophotometers, IonQuest Ion Chromatography and HPLC systems.
|
 |
 |
Celentyx Limited, United Kingdom |   |
|
|
| |
Celentyx’s unique Immuno-Profiling™ platform allows rapid analysis of drug action on human immune cells.
|
|
 |
Celerion, United States |    |
|
|
| |
Celerion is the privately owned CRO formed through the acquisition of the development and regulatory services consultancy and early clinical development operations of MDS Pharma Services.
|
 |
 |
Celgene Ltd, United Kingdom |  |
|
|
| |
Celgene is a pharmaceutical company with a major focus on the discovery, development and commercialization of small molecules for cancer and immunological diseases.
|
 |
 |
Cell Biosciences, Inc., United States |   |
|
|
| |
Cell Biosciences is a private life sciences company focused on defining the future of protein analysis. Our company develops instrumentation systems, software and assay products that drive discoveries in fields ranging from fundamental protein research to
|
|
 |
Cell Genesys, Inc., United States |  |
 |
|
| |
Cell Genesys is focused on the development and commercialization of innovative therapeutic products for cancer based on gene therapy technologies
|
|
 |
CellAura Technologies Ltd, United Kingdom |    |
|
|
| |
CellAura Technologies: your source of innovative fluorescent products for life science and drug discovery
|
 |
 |
CellCentric Ltd, United Kingdom |  |
|
|
| |
CellCentric represents leadership in epigenetic understanding and its application to therapeutic and non-clinical applications.
|
 |
 |
Celldex Therapeutics, United Kingdom |   |
|
|
| |
Celldex: Exploiting recent scientific breakthroughs to develop
the next generation of targeted immunotherapeutics
|
 |
 |
Celleron Therapeutics, United Kingdom |  |
|
|
| |
Celleron Therapeutics is an oncology healthcare company dedicated to developing unique cancer therapies and technologies that improve the performance of regular cancer treatments.
|
|
 |
CellGate Inc, United States | |
|
|
| |
Progen Pharmaceuticals Limited (NASDAQ:PGLA; ASX: PGL) is a globally focused biotechnology company committed to improving patient outcomes through discovery and development of small molecule-based cancer therapeutics.
|
|
 |
CellGenix Technologie Transfer GmbH, United States |  |
|
|
| |
CellGenix develops, manufactures and markets cell and protein therapeutics for tumor and orthopedic patients, as well as high-quality reagents for therapeutic ex vivo cell processing.
|
 |
 |
Cellomics, Inc., United States | |
|
|
| |
Cellomics, Inc. is automating drug discovery through a unique, cell-based assay platform that addresses the needs of Drug Discovery and Systems Biology groups by offering complete systems for High Content Screening (HCS).
|
 |
 |
Cellprep Celular Biotech, Argentina |  |
|
|
| |
CellPrep S.A. is an argentine biotechnology company committed to the research and development of cell processing techniques and practices applied in different fields of medicine
|
 |
 |
Cellular Engineering Technologies Inc, United States | |
|
|
| |
Cellular Engineering Technologies (CET), founded in 2000, is an emerging biotechnology company in tissue engineering focused on developing novel technologies to expedite the drug discovery and screening processes.
|
|
 |
Cellular Genomics, Inc., United States |  |
|
|
| |
CGI has assembled a suite of powerful technologies designed to set new standards in genomic-based drug discovery
|
 |
 |
CeNeRx BioPharma, United States | |
|
|
| |
CeNeRx BioPharma is a high growth drug development company with a therapeutic focus on diseases of the central nervous system. The company focuses on identifying and developing promising therapeutics to treat diseases related to neurotransmitters and the
|
 |
 |
CeNeS Pharmaceuticals plc, United Kingdom |  |
 |
|
| |
Cambridge NeuroScience (CNSI) is engaged in the discovery and development of pharmaceutical products to treat severe disorders and injuries of the nervous system, including stroke, traumatic brain injury, Alzheimer's disease and multiple sclerosis.
|
|
 |
Cengent Therapeutics Inc - Corporate HQ, United States |  |
|
|
| |
We provides a comprehensive suite of structural services and capabilities for accelerating and optimizing the drug discovery process.
|
|
 |
Cenix BioScience GmbH, Germany |   |
|
|
| |
Cenix BioScience is a specialist in advanced, cell-based applications of RNA interference (RNAi), a breakthrough gene silencing technology for the discovery and functional characterization of novel therapeutic targets and drug candidates.
|
 |
 |
CenTec Ltd, Australia |  |
|
|
| |
Medical research is becoming an increasingly vital part of all our lives. The discoveries in disease prevention and therapy have prolonged our productive lifespans and we are increasingly being able to tailor medicines to benefit the individual.
|
|
 |
Centre for Human Drug Research, Netherlands |  |
|
|
| |
CHDR performs research with new medicines in humans and operates a high quality research unit to do this. CHDR has a unique position among early phase drug development research organisations.
|
 |